Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis.
about
Whey protein lowers blood pressure and improves endothelial function and lipid biomarkers in adults with prehypertension and mild hypertension: results from the chronic Whey2Go randomized controlled trialCircadian misalignment increases cardiovascular disease risk factors in humansHeritability of metabolic syndrome traits in a large population-based sample.Imputing observed blood pressure for antihypertensive treatment: impact on population and genetic analyses.Symptoms of anxiety and depression across adulthood and blood pressure in late middle age: the 1946 British birth cohort.Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response.Out-of-office blood pressure: from measurement to controlTwenty-four-hour ambulatory blood pressure monitoring in hypertension: an evidence-based analysis.Changes in home versus clinic blood pressure with antihypertensive treatments: a meta-analysisAdministration time-dependent effects of combination therapy on ambulatory blood pressure in hypertensive subjects.Low-sodium dietary approaches to stop hypertension diet reduces blood pressure, arterial stiffness, and oxidative stress in hypertensive heart failure with preserved ejection fraction.Prevention of cardiovascular disease guided by total risk estimations--challenges and opportunities for practical implementation: highlights of a CardioVascular Clinical Trialists (CVCT) Workshop of the ESC Working Group on CardioVascular PharmacoloMasked hypertension in diabetes mellitus: treatment implications for clinical practice.Blood pressure changes after renal denervation at 10 European expert centers.Recent advances in the management of hypertension.Brain angiotensin AT1 receptors as specific regulators of cardiovascular reactivity to acute psychoemotional stress.Twenty-four-hour ambulatory blood pressure measurement in clinical practice and research: a critical review of a technique in need of implementation.Diagnosis and management of patients with white-coat and masked hypertension.Carotid baroreceptor activation for the treatment of resistant hypertension and heart failure.Renal denervation in the treatment of drug-resistant hypertension: current knowledge and future perspectives.Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoring.Renal denervation in the treatment of hypertension.Renal sympathetic denervation: applications in hypertension and beyond.Blood pressure variability over 24 h: prognostic implications and treatment perspectives. An assessment using the smoothness index with telmisartan-amlodipine monotherapy and combination.Renal denervation--implications for chronic kidney disease.Managing hypertension with ambulatory blood pressure monitoring.Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.Efficacy and safety of renal denervation for Chinese patients with resistant hypertension using a microirrigated catheter: study design and protocol for a prospective multicentre randomised controlled trial.Effort-Reward Imbalance at Work and the Prevalence of Unsuccessfully Treated Hypertension Among White-Collar Workers.Device-Based Therapy for Drug-Resistant Hypertension: An Update.Advantages of Ambulatory Blood Pressure Monitoring in Assessing the Efficacy of Antihypertensive Therapy.Prevalence of high blood pressure measured in the Brazilian population, National Health Survey, 2013.Office and ambulatory blood pressure control in hypertensive patients treated with different two-drug and three-drug combinations.Supplement: Cardiology and Therapy.Improvements in insulin sensitivity and muscle blood flow in aerobic-trained overweight-obese hypertensive patients are not associated with ambulatory blood pressure.[Reproducibility of arterial pressure measured in the ELSA-Brasil with 24-hour pressure monitoring].Associations between cellular aging markers and metabolic syndrome: findings from the CARDIA study.Size of blood pressure reduction from renal denervation: insights from meta-analysis of antihypertensive drug trials of 4,121 patients with focus on trial design: the CONVERGE report.Birth weight, hypertension and "white coat" hypertension: size at birth in relation to office and 24-h ambulatory blood pressure.Efficacy and tolerability of initial high vs low doses of S-(-)-amlodipine in hypertension.
P2860
Q28109651-78F864CF-6F8B-4E3E-AB53-555DF0791D10Q28389594-06A56D5F-4115-4013-8D43-F696F15433FBQ30410470-A245AC1A-E100-4713-8A08-CE395C6811DBQ33598411-308D6F6E-5FCF-43A3-BB7D-DB5A61ACC5E6Q34196866-12498958-8858-42B0-B518-D0273BDF3F86Q35927819-3CC1322B-858D-41E4-B3E8-384FF808CE73Q35997369-95953AD2-D4AF-466C-83F1-780071D486E0Q36039995-5FB6187F-8F3D-4AFE-B881-758468DCBDE8Q36122212-C3C30932-32C8-4D02-AC38-268503F883E3Q36412158-A31793D9-C04F-4C74-812F-59930E817CC0Q36467508-008736D4-7C4D-449C-873B-0C54A4F2CF27Q36613362-5B289E7A-0076-4831-B492-444C090CA962Q36780516-26825DB2-E64C-4760-A678-5FD2C3AB4C93Q37598844-2A17E52B-0B3F-4052-957B-5787BC47363FQ37800374-623BEFD9-85BF-4BA7-BDF2-BDEB92272A0EQ37818513-6A6A81FF-6501-42DD-817A-7768BE0850C3Q37833661-DBCEBD53-A029-4D80-9EA2-DCF11F5306C8Q37913971-A84B900A-EE93-4965-BA1F-358BEB40AC04Q37997994-FD076EC7-724D-4A3F-AB0B-BB6C58D42CFEQ38088274-A4CFF6F0-E135-44E2-A47C-132BB6E2D26CQ38103399-9420B7A1-6B28-4FC2-9AE4-9C066019FAEDQ38112364-F14B9ED2-C592-472E-82AE-566282938375Q38115114-4E8D22FB-774B-4F12-9E42-D6840AE993E1Q38168671-EA1EC263-7C31-46FE-84F5-D8EF5A7B5A0AQ38204682-318943D8-2FE6-482A-92BE-A66BE5838251Q38331093-8468DEAD-8671-4FC8-BFFC-6E47B78BF87CQ38384615-A99FC82F-E711-4F29-8263-77868FC64F60Q38597202-0E33D13F-9C68-4843-936C-136290A30B25Q38795689-88E4F542-2338-4676-91BA-8690B5DCF88AQ38893138-90778AE4-39FC-4FBA-BDBF-22DF997412ADQ38995259-6EF8FACB-CBBD-4658-AF30-E760ECC8327BQ39736904-8CEB3830-4C87-43BA-B381-F1AEADC62B3BQ39782957-26DF688A-3D0B-489B-B85F-6D76863D0D5AQ42361560-B49631B1-218D-418B-8642-D400321D4FF2Q43439797-96FB7C06-58C7-4C65-88CA-47FC5C74A87BQ44924648-1BE8720D-CA67-4A74-9BE6-F07ADF2F35C8Q45953923-681A5424-6474-4B85-9127-C3725A00D5EBQ47210860-BBA6CE3B-46CA-4623-906A-787B116D60D0Q47379116-9F0790D6-45F8-40A9-97DD-B17D938D1399Q48353216-45B0E089-061F-4101-9AFA-FF3BCB3BACA9
P2860
Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Office compared with ambulator ...... ve treatment: a meta-analysis.
@ast
Office compared with ambulator ...... ve treatment: a meta-analysis.
@en
type
label
Office compared with ambulator ...... ve treatment: a meta-analysis.
@ast
Office compared with ambulator ...... ve treatment: a meta-analysis.
@en
prefLabel
Office compared with ambulator ...... ve treatment: a meta-analysis.
@ast
Office compared with ambulator ...... ve treatment: a meta-analysis.
@en
P1476
Office compared with ambulator ...... ve treatment: a meta-analysis.
@en
P2093
Gianfranco Parati
P304
P356
10.1097/00004872-200403000-00001
P577
2004-03-01T00:00:00Z